BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25512434)

  • 1. Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction.
    Jones DA; Pellaton C; Velmurugan S; Rathod KS; Andiapen M; Antoniou S; van Eijl S; Webb AJ; Westwood MA; Parmar MK; Mathur A; Ahluwalia A
    Circ Res; 2015 Jan; 116(3):437-47. PubMed ID: 25512434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).
    Siddiqi N; Bruce M; Neil CJ; Jagpal B; Maclennon G; Cotton SC; Papadopoulo SA; Bunce N; Lim P; Schwarz K; Singh S; Hildick-Smith D; Horowitz JD; Madhani M; Boon N; Kaski JC; Dawson D; Frenneaux MP
    J Transl Med; 2013 May; 11():116. PubMed ID: 23648219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial.
    Jones DA; Andiapen M; Van-Eijl TJ; Webb AJ; Antoniou S; Schilling RJ; Ahluwalia A; Mathur A
    BMJ Open; 2013; 3(4):. PubMed ID: 23550096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
    Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI).
    Siddiqi N; Neil C; Bruce M; MacLennan G; Cotton S; Papadopoulou S; Feelisch M; Bunce N; Lim PO; Hildick-Smith D; Horowitz J; Madhani M; Boon N; Dawson D; Kaski JC; Frenneaux M;
    Eur Heart J; 2014 May; 35(19):1255-62. PubMed ID: 24639423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of intracoronary reteplase during primary percutaneous coronary intervention on infarct size in large anterior myocardial infarction: rationale and design of the RECOVER II trial.
    Huang D; Ma Y; Wu H; Zhong X; Gao W; Zhou J; Qian J; Ge J
    Cardiovasc Diagn Ther; 2022 Jun; 12(3):352-359. PubMed ID: 35800360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
    Jones DA; Khambata RS; Andiapen M; Rathod KS; Mathur A; Ahluwalia A
    Heart; 2017 Apr; 103(7):508-516. PubMed ID: 27683405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
    Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
    Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
    Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.
    Stone GW; Martin JL; de Boer MJ; Margheri M; Bramucci E; Blankenship JC; Metzger DC; Gibbons RJ; Lindsay BS; Weiner BH; Lansky AJ; Krucoff MW; Fahy M; Boscardin WJ;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):366-75. PubMed ID: 20031745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction.
    Chan W; Taylor AJ; Ellims AH; Lefkovits L; Wong C; Kingwell BA; Natoli A; Croft KD; Mori T; Kaye DM; Dart AM; Duffy SJ
    Circ Cardiovasc Interv; 2012 Apr; 5(2):270-8. PubMed ID: 22496085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium Nitrite-Mediated Cardioprotection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Cost-Effectiveness Analysis.
    Jones DA; Whittaker P; Rathod KS; Richards AJ; Andiapen M; Antoniou S; Mathur A; Ahluwalia A
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):113-119. PubMed ID: 30081658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
    Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
    J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.
    Stone GW; Maehara A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH; Ochala A; Carlton TW; Cristea E; Wolff SD; Brener SJ; Chowdhary S; El-Omar M; Neunteufl T; Metzger DC; Karwoski T; Dizon JM; Mehran R; Gibson CM;
    JAMA; 2012 May; 307(17):1817-26. PubMed ID: 22447888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    ; Bates E; Bode C; Costa M; Gibson CM; Granger C; Green C; Grimes K; Harrington R; Huber K; Kleiman N; Mochly-Rosen D; Roe M; Sadowski Z; Solomon S; Widimsky P
    Circulation; 2008 Feb; 117(7):886-96. PubMed ID: 18250271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial.
    Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E
    BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Traverse JH; Swingen CM; Henry TD; Fox J; Wang YL; Chavez IJ; Lips DL; Lesser JR; Pedersen WR; Burke NM; Pai A; Lindberg JL; Garberich RF
    Circ Res; 2019 Mar; 124(5):769-778. PubMed ID: 30602360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.